Venaxis (NASDAQ: APPY) announced its support of key findings from a large retrospective study that was published earlier this week ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE